James S Tisch has an estimated net worth of $2.47 Billion. This is based on reported shares across multiple companies, which include GENERAL ELECTRIC CO, DIAMOND OFFSHORE DRILLING, INC., INCYTE CORP, LOEWS CORP, SYNAGEVA BIOPHARMA CORP, BKF CAPITAL GROUP INC, CELLEGY PHARMACEUTICALS INC, NEUROGEN CORP, and CNA FINANCIAL CORP.
2007 was James S Tisch's most active year for acquiring shares with 41 total transactions. James S Tisch's most active month to acquire stocks was the month of December. 2007 was James S Tisch's most active year for disposing of shares, totalling 70 transactions. James S Tisch's most active month to dispose stocks was the month of January. 2025 saw James S Tisch paying a total of $25,001,288.28 for 563,112.5 shares, this is the most they've acquired in one year. In 2025 James S Tisch cashed out on 615,112 shares for a total of $31,120,097.41, their largest year based on trade value.